Literature DB >> 23592892

Treatment of mesothelioma: still a long way to go!

Paul E Van Schil1.   

Abstract

Entities:  

Year:  2013        PMID： 23592892      PMCID： PMC3626977          DOI： 10.3978/j.issn.1000-9604.2013.01.11

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN： 1000-9604            Impact factor:   5.087


× No keyword cloud information.
  8 in total

1.  Mesothelioma incidence projections in South East England.

Authors:  Sharma P Riaz; Victoria H Coupland; Margreet Lüchtenborg; Michael D Peake; Henrik Møller
Journal:  Eur Respir J       Date:  2012-01-26       Impact factor: 16.671

2.  Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial.

Authors:  P E Van Schil; P Baas; R Gaafar; A P Maat; M Van de Pol; B Hasan; H M Klomp; A M Abdelrahman; J Welch; J P van Meerbeeck
Journal:  Eur Respir J       Date:  2010-06-04       Impact factor: 16.671

Review 3.  Malignant pleural mesothelioma: staging systems.

Authors:  P Van Schil
Journal:  Lung Cancer       Date:  2005-03-29       Impact factor: 5.705

4.  Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the international association for the study of lung cancer international staging committee and the international mesothelioma interest group.

Authors:  David Rice; Valerie Rusch; Harvey Pass; Hisao Asamura; Takashi Nakano; John Edwards; Dorothy J Giroux; Seiki Hasegawa; Kemp H Kernstine; David Waller; Ramon Rami-Porta
Journal:  J Thorac Oncol       Date:  2011-08       Impact factor: 15.609

5.  Initial analysis of the international association for the study of lung cancer mesothelioma database.

Authors:  Valerie W Rusch; Dorothy Giroux; Catherine Kennedy; Enrico Ruffini; Ayten K Cangir; David Rice; Harvey Pass; Hisao Asamura; David Waller; John Edwards; Walter Weder; Hans Hoffmann; Jan P van Meerbeeck
Journal:  J Thorac Oncol       Date:  2012-11       Impact factor: 15.609

6.  Modified RECIST criteria for assessment of response in malignant pleural mesothelioma.

Authors:  M J Byrne; A K Nowak
Journal:  Ann Oncol       Date:  2004-02       Impact factor: 32.976

7.  Systematic review of trimodality therapy for patients with malignant pleural mesothelioma.

Authors:  Christopher Cao; David Tian; Con Manganas; Phoebe Matthews; Tristan D Yan
Journal:  Ann Cardiothorac Surg       Date:  2012-11

8.  Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study.

Authors:  Tom Treasure; Loic Lang-Lazdunski; David Waller; Judith M Bliss; Carol Tan; James Entwisle; Michael Snee; Mary O'Brien; Gill Thomas; Suresh Senan; Ken O'Byrne; Lucy S Kilburn; James Spicer; David Landau; John Edwards; Gill Coombes; Liz Darlison; Julian Peto
Journal:  Lancet Oncol       Date:  2011-06-30       Impact factor: 41.316
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.